ABSTRACT-The tumor promoter anthralin stimulated prostaglandin E2 (PGE2) and arachidonic acid release from primary cultures of mouse epidermal cells. Epidermal growth factor (EGF) hardly stimulated PGE2 release by itself; however, a combina tion of anthralin and EGF synergistically stimulated PGE2 release. Neither anthralin, EGF nor EGF plus anthralin affected the incorporation of arachidonic acid into cellu lar phospholipids at least up to 2 hr after the stimulation by these agents. In the pres ence of EGF, however, [3H]arachidonic aicd in the medium decreased substantially 4 -8 hr after the addition of this agent , indicating that EGF suppresses [3H]arachidonic acid release and stimulates the incorporation of [3H]arachidonic acid into the cells during this time period. Cellular cyclooxygenase activity was increased by treating the cells either with anthralin or EGF, and it was synergistically increased by EGF plus anthralin. Both cycloheximide and actinomycin D inhibited the increase in cyclooxygen ase activity caused by EGF plus anthralin. These results indicate that the synergistic stimulation of PGE2 release caused by EGF plus anthralin is due to a synergistic stimu lation of arachidonic acid release (in the early phase of stimulation) and a synergistic increase in cyclooxygenase activity, probably a synergistic induction of cyclooxygen ase, by these agents.
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In the two-stage carcinogenesis of mouse skin, tumor promoters are generally classified as 12-O-tetradecanoylphorbol-13-acetate (TPA) type and non-TPA type tumor promoters. TPA-type tumor promoters interact with pro tein kinase C and activate it, whereas non TPA type tumor promoters do not interact with protein kinase C. TPA stimulates arach idonic acid metabolism in primary cultures of mouse epidermal cells (1), i.e., the target cells of skin tumor promotion. A non-TPA type of tumor promoter, anthralin (2), also stimulates prostaglandin E2 (PGE2) release in these cells (1) . Anthralin not only stimulates PGE2 re lease by itself but also synergistically potenti ates TPA-caused PGE2 release (E. Aizu et al., manuscript in preparation). The potentia tion of TPA-caused PGE2 release is not a common feature of the non-TPA type tumor promoters (E. Aizu 
MATERIALS AND METHODS

Materials
The sources of materials used in this study were as follows: anthralin, indomethacin, from Sigma Chemical Co., St Louis, MO; EGF, from Toyobo Co., Ltd., Osaka, Japan; [3H]arachidonic aicd (230 Ci/mmol), from Amersham Laboratories, Buckinghamshire, UK; The other chemicals used were of reagent grade.
Primary cultures of epidermal cells
Epidermal cells were isolated from new born CD-I mice and cultured in Ca 2+-free minimum essential medium (MEM) supple mented with 10% Chelex-treated (Ca 2+-de prived) fetal calf serum and 50 ,u M CaCl2 (final concentration) at 36°C in an atmosphere of 92% air/8% C02, as described previously (3, 4) . All experiments were performed with confluent cells at 4 days of culture (3, 4) .
Measurement of [3HJarachidonic acid and [3HJPGE2 release
Epidermal cells cultured in 35-mm-diameter dishes were prelabeled with 1 ,uCi/2 ml/dish of [3H]arachidonic acid for 24 hr (1); there after, the cells were stimulated with the indi cated agents, and the amounts of [3H]PGE2 and [3H]arachidonic acid released into the medium were determined as described pre viously (1).
Incorporation of [3H]arachidonic acid into phospholipids
Epidermal cells in 35 mm-diameter dishes were incubated in Ca 2+-free MEM supple mented with 50 ,uM CaC12 (final concentration) and 0.5% bovine serum albumin (final concen tration), but without fetal calf serum in the presence or absence of the indicated agents at 36°C for 90 min; thereafter, [3H]arachidonic acid (0.1 u Ci) was added to the incubation medium, and the cells were incubated for another 30 min. After the incubation, cells were washed and scraped off. Cellular phos pholipids were extracted with chloroform/ methanol (1:2, v/v) and subjected to thin layer chromatography (Whatman LK6D) with a solvent system of chloroform/methanol/acetic acid/0.9% NaC1 (50:25:8:4, v/v). Rf values of phosphatidylcholine, phosphatidylserine plus phosphatidylinositol and phosphatidylethanol amine were 0.53, 0.68 and 0.89, respectively. Each phospholipid fraction was scraped into the counting vial, and radioactivity was deter mined by a liquid scintillation counter. Under our experimental conditions, the incorporation of [3H]arachidonic acid into cellular phospho lipids increased linearly at least up to 30 min after the addition of [3H]arachidonic acid into the medium.
Cyclooxygenase assay
Epidermal cells in 60-mm dishes were incu bated in the Ca 2+-free MEM supplemented with 50 ,uM CaC12 (final concentration) and 0.5% bovine serum albumin (final concentra tion) but without fetal calf serum in the pres ence or absence of the indicated agents, cycloheximide, actinomycin D, EGF and/or anthralin, at 36°C for the indicated time periods. After the incubation, the cells were collected and sonicated in the homogenizing buffer consisting of 100 mM Tris-HCl (pH 8.0), 1 mM EDTA, 2 mM reduced glutathione and 2,uM hemoglobin. The resultant cellular homogenate (150 300 ,u g protein/ml) was in cubated with 50,uM [3H]arachidonic acid (spe cific activity, 20 mCi/mmol) in the presence or absence of 10 ,uM indomethacin at 37°C for 10 min. Indomethacin-sensitive formation of
[3H]PGE2 was determined as described pre viously (5).
RESULTS
When
[3H]arachidonic acid-prelabeled epidermal cells were incubated with 10 ,u M anthralin, release of [3H]PGE2 into the medium was stimulated after a 4 6 hr lag period (Fig. 1) , consistent with our previous observations (1) . This concentration of anthra lin induces the maximal PGE2 release in these cells (1) . Release of [3H]arachidonic acid into the medium was also stimulated by anthralin after a similar lag period (Fig. 1) . On the other hand, 10 ng/ml EGF, a concentration sufficient to induce a maximal cellular re sponse such as ornithine decarboxylase induc tion in these cells (our unpublished data), did not stimulate [3H]PGE2 release throughout the observation period (Fig. 1) . A higher con centration of EGF (30 ng/ml) also failed to in duce PGE2 release (data not shown). At 30 min after the addition of EGF, [3H]arachidon ic acid released into the medium was stimulat ed transiently, but [3H]arachidonic acid in the medium rather decreased 4-8 hr after EGF stimulation (Fig. 1) .
The combined addition of EGF plus anthra lin caused a marked synergistic stimulation of [3H]PGE2 release in a time-dependent manner (Fig. 1). [3H]PGE2 release was stimulated within 0.5-2 hr after the addition of these agents. The release of [3H]arachidonic acid was also stimulated at least up to 2 hr after the addition of EGF plus anthralin. As shown in Fig. 2 ity. Cyclooxygenase activity in the cellular homogenate was determined by measuring the indomethacin-sensitive conversion of [3H] arachidonic acid into [3H]PGE2. When the cells were incubated with EGF for 2 hr or longer, cyclooxygenase activity in the cellular homogenates increased substantially (Fig. 3) . Anthralin also induced an increase in the cy clooxygenase activity, but the increase was de tected only after a 4-6 hr lag period (Fig. 3) . The cyclooxygenase activity was synergistically increased by treating the cells with EGF plus anthralin in an incubation time-dependent manner (Fig. 3) . Effects of cycloheximide and actinomycin D on the increase in cyclooxygen ase activity caused by EGF plus anthralin (4 hr-incubation) were also examined. Both cy cloheximide and actinomycin D inhibited the increase in cyclooxygenase activity caused by EGF plus anthralin: 10 ng/ml EGF + 10,uM anthralin, 298 pmol/mg protein/min; EGF + anthralin + 1 uM cycloheximide, 100 pmol/mg protein/min; EGF + anthralin + 0.1 ,ug/ml actinomycin D, 154 pmol/mg protein/min.
DISCUSSION
Anthralin stimulated the release of [3H]PGE2 and [3H]arachidonic acid from [3H]arachidonic acid-prelabeled epidermal cells after a 4 6 hr lag period. The release of arachidonic acid from membrane phospho lipids is generally considered to be the rate limiting step of prostaglandin synthesis. Evi dence is accumulating, however, that de novo synthesis of prostaglandin synthase, i.e., cyclo oxygenase, can be important in governing the rate of prostaglandin formation (6) . Treatment of the cells with anthralin also caused an in crease in cellular cyclooxygenase activity after a 4 6 hr lag period. Since treatment of the cells with cycloheximide or actinomycin D in hibited anthralin-caused increases in cyclooxy genase activity (E. Aizu et al., manuscript in preparation), it seems likely that anthralin in ceases cyclooxygenase activity through the in ducition of this enzyme. These results clearly indicate that the stimulation of PGE2 release by anthralin is due to a stimulation of arach idonic acid release and an increase in cyclo oxygenase activity, probably an induction of cyclooxygenase, by this agent. It has been reported that EGF stimulated the release of PGE2 from mouse osteoblastic cells (7), human amnion cells (8) and rat glomerular mesangial cells (9) Arach idonic acid released into the medium was tran siently but synergistically increased by EGF plus anthralin for at least up to 2 hr after the addition of these agents. Since this apparent increase in [3H]arachidonic acid release by these agents was not due to the decrease in the incorporation of arachidonic acid into phos pholipids, release of arachidonic acid would actually be stimulated by these agents. These results suggest that the synergistic stimulation of PGE2 release caused by EGF plus anthralin is due to a synergistic stimulation of arachidon ic acid release (in the early phase of stimula tion) and a synergistic increase in cyclooxygen ase activity, probably a synergistic induction of cyclooxygenase, by these agents.
[3H]Arachidonic acid release caused by anthralin was apparently suppressed by EGF at 8 hr after the combined addition of these agents; nevertheless, [3H]PGE2 release was markedly stimulated, suggesting that the amount of [3H]arachidonic acid released into the medium does not always reflect the amount of free arachidonic acid which is avail able for cellular cyclooxygenase.
